Skip to main navigation
Skip to search
Skip to main content
Aston Research Explorer Home
Help & FAQ
Home
Research units
Profiles
Research Outputs
Datasets
Student theses
Activities
Press/Media
Prizes
Equipment
Search by expertise, name or affiliation
GIP analogues and the treatment of obesity-diabetes
Clifford J. Bailey
School of Biosciences
Biosciences Research Group (BRG)
College of Health and Life Sciences
Aston Research Centre for Health in Ageing
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'GIP analogues and the treatment of obesity-diabetes'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Clinical Studies
8%
Gastric Inhibitory Polypeptide
100%
gastric inhibitory polypeptide receptor
20%
Glucagon
12%
Glucagon Receptors
9%
Glucagon-Like Peptide 1
7%
Glucagon-Like Peptide-1 Receptor
15%
Glucose
3%
Incretins
8%
Obesity
47%
Obesity Management
8%
Peptides
15%
Rodentia
10%
Therapeutic Uses
5%
Therapeutics
11%
Type 2 Diabetes Mellitus
18%
Weight Loss
5%
Chemistry
Additive
3%
Agent Interacting With Transmitter, Hormone or Drug Receptor
5%
Agonist
4%
Antagonist
4%
Application
1%
Glucagon
19%
Glucagon-Like Peptide 1
15%
Glucagon-Like Peptide-1 Receptor Agonist
9%
Glycemic
7%
Insulinotropic
24%
Peptide
8%
Polypeptide
56%
Weight
2%